India Approves First Dengue Vaccine
In July 2026, India approved its first dengue vaccine, QDENGA, providing a new tool to reduce the country's growing dengue burden.
- The vaccine is approved for people aged 4-60 years, irrespective of previous dengue infection.
- Unlike some earlier dengue vaccines, QDENGA does not require pre-vaccination screening for past dengue infection.
- QDENGA is a live-attenuated tetravalent vaccine that provides protection against all four dengue virus serotypes (DENV-1, DENV-2, DENV-3 and DENV-4).
- The vaccine has been approved in over 40 countries and has received WHO prequalification, confirming its quality, safety and efficacy.
|
Mains ModelQuestions Q1. ISRO's successful ground .... |
Do You Want to Read More?
Subscribe Now
To get access to detailed content
Already a Member? Login here
Take Annual Subscription and get the following Advantage
The annual members of the Civil Services Chronicle can read the monthly content of the magazine as well as the Chronicle magazine archives.
Readers can study all the material since 2018 of the Civil Services Chronicle monthly issue in the form of Chronicle magazine archives.
Science & Technology
- 1 Indian Researchers Develop Placenta-on-Chip
- 2 INS Malvan
- 3 Vikram-1: India's First Private Orbital Rocket
- 4 Euclid Telescope Discovers the Oldest Known Quasars
- 5 Indian Researchers Develop New Method to Model the Topside Ionosphere
- 6 NASA’s Swift Boost Mission
- 7 ISRO Tests SOLVE Solid Motor
- 8 INS Mahendragiri Joins Indian Navy
- 9 ISRO Conducts Three Gaganyaan Tests
- 10 FCC Approves Sunlight Reflection Satellite
